Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions…
After businessman Lu Yong was charged with “the sale of fake drugs” and “impairing credit card administration”, the case once again set off debates over…